Acceso abierto

Effects of lipopolysaccharide administration on thymus damage, antioxidant capacity and immune function in weaned piglets

, , , , , , , ,  y   
25 mar 2025

Cite
Descargar portada

Fig. 1.

The nitric oxide (NO) secretion in the thymus of weaned piglets. CON – control group; LPS – lipopolysaccharide group; * – significant increase (P-value < 0.05); ** – highly significant increase (P-value < 0.01)
The nitric oxide (NO) secretion in the thymus of weaned piglets. CON – control group; LPS – lipopolysaccharide group; * – significant increase (P-value < 0.05); ** – highly significant increase (P-value < 0.01)

Fig. 2.

The mRNA expression of thymic toll-like receptor 4 (TLR4) pathway, related inflammatory factors and inducible nitric oxide synthase (iNOS). IL – interleukin; MyD88 – myeloid differentiation factor 88; NFκB – nuclear factor kappa B; TNF-α – tumour necrosis factor α; CON – control group; LPS – lipopolysaccharide group; * – significant increase (P-value < 0.05); ** – highly significant increase (P-value < 0.01); # – significant decrease (P-value < 0.05); ## – highly significant decrease (P-value < 0.01)
The mRNA expression of thymic toll-like receptor 4 (TLR4) pathway, related inflammatory factors and inducible nitric oxide synthase (iNOS). IL – interleukin; MyD88 – myeloid differentiation factor 88; NFκB – nuclear factor kappa B; TNF-α – tumour necrosis factor α; CON – control group; LPS – lipopolysaccharide group; * – significant increase (P-value < 0.05); ** – highly significant increase (P-value < 0.01); # – significant decrease (P-value < 0.05); ## – highly significant decrease (P-value < 0.01)

Fig. 3.

The mRNA expression of thymic JAK-STAT pathway and Keap1/Nrf2 pathway. A – janus kinase 1 (JAK1); B – kelch-like ECH-associated protein 1 (Keap1); C –signal transducer and activator of transcription 3 (STAT3); D – nuclear factor erythroid 2-related factor 2 (Nrf2). * – significant increase (P-value < 0.05); ** – highly significant increase (P-value < 0.01); # – significant decrease (P-value < 0.05); ## – highly significant decrease (P-value < 0.01)
The mRNA expression of thymic JAK-STAT pathway and Keap1/Nrf2 pathway. A – janus kinase 1 (JAK1); B – kelch-like ECH-associated protein 1 (Keap1); C –signal transducer and activator of transcription 3 (STAT3); D – nuclear factor erythroid 2-related factor 2 (Nrf2). * – significant increase (P-value < 0.05); ** – highly significant increase (P-value < 0.01); # – significant decrease (P-value < 0.05); ## – highly significant decrease (P-value < 0.01)

The antioxidant parameters in the thymus of weaned piglets

Group Day 1 Day 5 Day 9 Day 13
T-AOC (mmol/g protein) CON 0.1462 ± 0.00640 0.1077 ± 0.02364 0.0755 ± 0.01391 0.1027 ± 0.00941
LPS 0.1527 ± 0.01974 0.1189 ± 0.00409 0.0787 ± 0.00503 0.0960 ± 0.00266
CAT (U/mg protein) CON 1.3091 ± 0.12010 1.0701 ± 0.09588 1.1309 ± 0.04572 0.5535 ± 0.08402
LPS 2.2744 ± 0.16687** 1.3503 ± 0.14927* 1.0992 ± 0.16026 0.6420 ± 0.09374
SOD (U/mg protein) CON 15.4502 ± 1.37575 14.0568 ± 0.18257 9.0334 ± 0.31115 9.7733 ± 0.53686
LPS 14.4014 ± 1.02473 14.3906 ± 0.49276 9.8023 ± 0.31115* 9.3018 ± 0.20602
GSH-Px (U/mg protein) CON 15.5310 ± 1.45508 13.7160 ± 0.42498 13.5570 ± 0.60307 16.8665 ± 1.07325
LPS 22.0999 ± 1.2071* 18.0544 ± 1.9736* 17.5424 ± 2.1281* 21.4042 ± 1.58232**
MDA (nmol/mg protein) CON 0.3856 ± 0.02354 0.3444 ± 0.11768 0.2435 ± 0.08353 0.2268 ± 0.00967
LPS 0.3634 ± 0.04299 0.3772 ± 0.07952 0.1684 ± 0.4000 0.2365 ± 0.04973

Primers used in RT-qPCR analysis

Gene Primer sequence (5′-3′) Product size (base pairs) GenBank accession No.
GAPDH F: CCTGGAGAAACCTGCAAAATAR: AACCTGGTCCTCAGTGTAGCC 100 NM_001206359.1
TLR4 F: GACGAAGACTGGGTGAGGAATGAACR: CCTGGATGATGTTAGCAGCGATGG 124 NM_001113039.2
MyD88 F: CGTCTGGTCCATTGCTAGAACTCR: TTCTGATGGGCACCTGGAGAGAG 141 NM_001099923.1
NF-κB F: CTGAGGCTATAACTCGCTTGGTGACR: CATGTCCGCAATGGAGGAGAAGTC 131 NM_001114281.1
TNF-α F: TCTATTTTGGGATCATTGCCCR: CCAGCCCCTCATTCTCTTTCT 127 NM_214022.1
IL-2 F: ACTTTCCAGGATGCTCACR: ACTTCCTCCAGAGGTTTG 102 DQ852342.1
IL-6 F: ATAAGGGAAATGTCGAGGCTGTGCR: GGGTGGTGGCTTTGTCTGGATTC 93 NM_001252429.1
IL-10 F: GCATCCACTTCCCAACCAR: GCAACAAGTCGCCCATCT 108 NM_214041.1
JAK1 F: GACCGTCACCTGCTTTGAGAR: ACGAAGCTGATGTTGTCCGT 104 AB00601
STAT3 F: AGCCTCTCCGCAGAGTTCAAR: GCCCCCGTTCCCACAT 60 NM_001044580.1
iNOS F: CAGCGGGATGACTTTCCAAR: TTGCAAGCAAGATCCCCTTT 60 NM_001143690.1
Keap1 F: ACGACGTGGAGACAGAAACGTR: GCTTCGCCGATGCTTCA 56 NM_001114671.1
Nrf2 F: GCCCCTGGAAGCGTTAAACR: GGACTGTATCCCCAGAAGGTTGT 67 XM_003133500.5